🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial consisted of three parts, Part A, Part B, and Part C, and evalua...
Status
Completed
Location
Collaborative Neuroscience Network LLC
Start Date
2021-08-25
Trial ID
NCT05004181
The purpose of this study is to determine the safety and efficacy of SL-701...
Status
Completed
Location
University of Alabama
Start Date
2014-05
Trial ID
NCT02078648
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2025-10-07
Trial ID
NCT07204964
The purpose of this study is to learn about the safety and immune effects o...
Status
Completed
Location
Alliance for Multispecialty Research, LLC
Start Date
2023-12-20
Trial ID
NCT06182124
Treatments Being Tested
The study was planned to include patients with bladder tumors attending the...
Status
Recruiting
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2025-02-08
Trial ID
NCT06763354
Treatments Being Tested
Currently, abuse of prescription opioid analgesics and heroin is a serious ...
Status
Recruiting
Location
Clinilabs Drug Development Corporation
Start Date
2020-10-08
Trial ID
NCT04458545
The purpose of this study is to evaluate the safety and immunogenicity of L...
Status
Completed
Location
LG chem
Start Date
2018-05-25
Trial ID
NCT03467984
The overall aim of the study is to corroborate that a schedule consisting o...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00255047
This is a Phase 2, randomized, active-controlled, open-label study with a 3...
Status
Terminated
Location
Mobile Pediatric Clinic
Start Date
2018-06-01
Trial ID
NCT03550313
Treatments Being Tested
This study will evaluate the immunogenicity and tolerability of V503 (a mul...
Status
Completed
Location
Multiple Locations
Start Date
2009-08-27
Trial ID
NCT00943722
Treatments Being Tested